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The global impact of DNA methylation on alternative
splicing is largely unknown. Using a genome-wide
approach in wild-type and methylation-deficient em-
bryonic stem cells, we found that DNA methylation
can either enhance or silence exon recognition and
affects the splicing of more than 20% of alternative
exons. These exons are characterized by distinct ge-
netic and epigenetic signatures. Alternative splicing
regulation of a subset of these exons can be ex-
plained by heterochromatin protein 1 (HP1), which
silences or enhances exon recognition in a posi-
tion-dependent manner. We constructed an experi-
mental system using site-specific targeting of a
methylated/unmethylated gene and demonstrate a
direct causal relationship between DNA methylation
and alternative splicing. HP1 regulates this gene’s
alternative splicing in a methylation-dependent
manner by recruiting splicing factors to its methyl-
ated form. Our results demonstrate DNA methyla-
tion’s significant global influence on mRNA splicing
and identify a specific mechanism of splicing regula-
tion mediated by HP1.
INTRODUCTION
DNA methylation is an important epigenetic mark, significantly
contributing to natural human variation (Heyn et al., 2013). Exam-
ination of the full DNAmethylome revealed that DNAmethylation
has dual and opposing roles in the regulation of gene expression.
In promoter regions, DNA methylation is associated with tran-
scriptional repression, while in gene bodies, DNA methylation
is generally associated with high expression levels (Ball et al.,
2009; Laurent et al., 2010; Rauch et al., 2009). The understanding
that DNA methylation is significantly present in the bodies of1122 Cell Reports 10, 1122–1134, February 24, 2015 ª2015 The Authhighly transcribed genes led to speculation about its possible
biological role in transcription or subsequent processing of
active genes.
Alternative splicing contributes to proteome diversity. At least
95% of human multi-exon genes produce alternatively spliced
transcripts (Pan et al., 2008; Wang et al., 2008). High-resolution
bisulfite sequencing of the genomes of several organisms
showed an enrichment of DNA methylation in exons compared
to introns (Chodavarapu et al., 2010; Hodges et al., 2009; Lyko
et al., 2010). In addition, we previously found that gene regions
encoding constitutively spliced exons display higher levels of
methylation than those encoding alternatively spliced exons
(Gelfman et al., 2013). DNA methylation was also recently found
to be positively correlated with inclusion levels of alternative
exons (Maunakea et al., 2013). These correlations prompted
speculation that DNA methylation plays a role in the regulation
of alternative splicing.
Given the fact that splicing occurs co-transcriptionally, there
are two possible models for epigenetic regulation of splicing:
(1) a kinetic model, in which an epigenetic modification affects
the kinetics of transcriptional elongation that subsequently im-
pacts splicing, and (2) a recruitment model, in which splicing
regulation occurs through adaptor proteins that bind to epige-
netic modifications and recruit splicing factors (Iannone and
Valca´rcel, 2013). Several recent studies now support methyl-
ation-regulated splicing via a kinetic model. Transcriptional
repressors such as CTCF and MeCP2 were found to modify
the elongation rate of RNA polymerase II (RNAPII) in a methyl-
ation-dependent manner, which in turn enhances (MeCP2) or
disturbs (CTCF) the efficiency of splicing (Maunakea et al.,
2013; Shukla et al., 2011). In support of the recruitment model
for other epigenetic modifications, the histone modification
H3K36me3 was found to recruit the splicing factors PTB (Luco
et al., 2010) and SRSF1 (Pradeepa et al., 2012). However, to
date, DNA methylation has not been found to participate in any
recruitment mechanism that affects splicing.
For DNA methylation to regulate splicing, it likely has a medi-
ator protein that can affect splicing regulation on the one handors
and is selective to DNA methylation on the other. One promising
candidate is heterochromatin protein 1 (HP1), which has three
isoforms in humans: HP1a, HP1b, and HP1g. All HP1 proteins
bind directly via their chromodomains to H3K9me3 (Bannister
et al., 2001; Jacobs and Khorasanizadeh, 2002), a histone modi-
fication that is induced by DNA methylation (Hashimshony et al.,
2003). Some HP1 isoforms have been previously linked to
splicing regulation in specific cases (Allo´ et al., 2009; Ameyar-
Zazoua et al., 2012; Saint-Andre´ et al., 2011; Schor et al.,
2013; Smallwood et al., 2012). The combined evidence that
HP1 can act as a splicing regulator in some contexts and also as-
sociates with H3K9me3, a histone modification that is co-local-
ized with regions of methylated DNA, makes HP1 a potential
candidate protein that regulates alternative splicing in a methyl-
ation-dependent manner.
Given that DNA methylation plays a role in the regulation of
mRNA splicing, a whole-genome analysis can decipher the
extent and magnitude of the global impact of DNA methylation
on splicing and uncover underlying trends and patterns. To
what extent does DNAmethylation affect splicing? Does it affect
all exons or only a specific group with specific characteristics?
Also, do HP1 proteins work in concert with methylation to create
a combined regulatory effect? To address these questions and
more, we used a genome-wide approach and found that more
than 20% of all alternative exons are affected by the absence
of DNA methylation; for these exons, DNA methylation acts as
either an enhancer or a silencer of splicing recognition. We char-
acterized these methylation-affected exons and found that they
possess specific genetic and epigenetic signatures that distin-
guish them from other exons. We applied our genome-wide
approach to analyze the effect of HP1 proteins on splicing and
found that these proteins also affect the inclusion level of a large
amount of alternative exons, again acting as either splicing en-
hancers or silencers depending on the context of their binding
to the exon. Splicing regulation through HP1 explains a signifi-
cant portion of the overall effect of DNA methylation on splicing.
To validate these findings, we established a novel experimental
system that specifically targets DNA methylation to a single
gene, and to that gene alone, and offer the first clear evidence
that DNA methylation regulates alternative splicing directly,
acting as a splicing enhancer in this case. HP1 also regulates
alternative splicing in this system and acts as a splicing silencer.
Finally, we decipher HP1’s regulatory mechanism and provide a
strong link between DNA methylation and alternative splicing via
a recruitment model, i.e., by recruiting splicing factors to methyl-
ated alternative exons through an adaptor protein, HP1.
RESULTS
Altered DNA Methylation Patterns Affect Alternative
Splicing Globally
The emerging picture from previous studies supports an impor-
tant link between DNA methylation and splicing (Gelfman et al.,
2013; Maunakea et al., 2013; Shukla et al., 2011). However,
the extent andmagnitude of this impact and its underlying trends
and patterns are still not fully known. To address this issue, we
performed RNA sequencing (RNA-seq) experiments on wild-
type (R1) and Dnmt1/3a/3b triple-knockout (TKO) mouse embry-Cell Ronic stem cells (ESCs) that lack DNA methyltransferase activity,
which results in unmethylated DNA in these cells (Melcer et al.,
2012; Tsumura et al., 2006). The TKO cells continue to grow
robustly, maintain their undifferentiated characteristics, and
display morphological features similar to wild-type undifferenti-
ated ESCs (Tsumura et al., 2006). We determined the inclusion
levels of 14,987 alternative cassette exons in each cell type using
RNA-seq. We next filtered the results based on very stringent
read-depth criteria (see Supplemental Experimental Proce-
dures). Of 3,376 alternative exons that met our criteria, inclusion
levels of 752 (22.2%) differed by more than 10% in TKO
compared to wild-type cells: 271 exons (8% of all alternative
exons) decreased their inclusion level in TKO cells, which means
that they were positively affected by methylation in the wild-type
cells, and 481 exons (14.2% of all alternative exons) increased
their inclusion level in TKO cells and thus were negatively
affected by methylation in the wild-type (Figures 1A and S1A).
These results indicate that DNA methylation can influence
alternative splicing in both directions, having both positive
(enhancing) and negative (silencing) roles in exon recognition.
RT-PCR analysis of selected exons further validated these find-
ings, supporting RNA-seq results in 93% of the cases (Fig-
ure S1B). We analyzed RNA expression levels of all spliceosome
components in wild-type and TKO cells and found no significant
changes (Table S1), implying that most of the changes in alterna-
tive splicing in TKO cells are a direct outcome of DNA methyl-
ation removal and not variations in quantities of splicing factors.
We also performed differential expression analyses between
wild-type and TKOcells for all mouse genes, revealing onlyminor
overall differences in expression (Table S2). This finding fits well
with previous knowledge that in mouse ESCs, CpG island
promoters are not usually repressed by DNA methylation and
are instead silenced by H3K27methylation (Smith andMeissner,
2013).
To study the connection between a methylation-related effect
and DNA methylation signal patterns, we performed whole-
genome bisulfite sequencing at 103 coverage in wild-type R1
cells and mapped the methylation profile at single-base resolu-
tion. We then examined methylation levels in exons and
their flanking intronic regions. Constitutive exons exhibited high
methylation levels, whereas alternative exons, in general, ex-
hibited lower levels ofmethylation (Figure 1B), aswas also shown
previously (Gelfman et al., 2013). This can imply that DNAmethyl-
ation promotes exon inclusion, but our results suggest that the
underlying mechanism is more complex. Constitutive exons
in wild-type cells remain constitutive for the most part in TKO
cells (98.5% of exons; data not shown), probably since their
sequence-based splicing signals strongly support recognition
by the splicing machinery, overshadowing the weaker DNA
methylation effect. However, alternative exons that aremore sen-
sitive to regulation by DNA methylation show different levels of
DNAmethylation (Figure 1B). Exons thatwere negatively affected
by methylation had significantly higher levels of methylation than
positively affected exons (+40%–50% exonic; t test, p value <
3.243 1010), while alternative exons unaffected by methylation
were found exactly between these two groups, with intermediate
methylation values. This result suggests that when the exonic
splicing signals are weaker (as is the case with alternative exons)eports 10, 1122–1134, February 24, 2015 ª2015 The Authors 1123
Figure 1. The Global Effect of DNA Methylation on Splicing Regulation
(A) Distribution of alternative exons based on direction of change in splicing pattern from TKO (unmethylated) to R1 (methylated) cells.
(B) Average of methylated CpGs for alternative (three groups) and constitutive exons.
(C) Average length of upstream introns (left), exons (center), and downstream introns (right) for alternative (three groups) and constitutive exons.
(D) G+C content for alternative (three groups) and constitutive exons. Right panel is a close-up of the first 100 nt downstream of the 50 splice site (50ss).
(E) Average score of the 30 splice sites for alternative (three groups) and constitutive exons based on a PSSM calculation (Amit et al., 2012).
(F) Average score of the 50 splice sites for alternative (three groups) and constitutive exons.
(G) PhastCons conservation values for alternative (three groups) and constitutive exons. Error bars represent the SEM.
(H) Nucleosome occupancy in R1 cells for alternative (three groups) and constitutive exons.
The average values given in (B), (D), and (H) were calculated per base for exons (75 nt from each splice site) and flanking intronic regions (200 nt), and a running
average was applied. See also Figure S1.and the recognition of the exon is not strongly controlled by the
basic splicing recognition factors, DNA methylation allows the
fine-tuningof this recognition. In this case, highmethylation levels
will repress recognition of exons, while lowmethylation levels will
enhance their recognition.
We next sought to better understand what defines the sub-
groups of exons that are regulated by DNAmethylation. Interest-
ingly, exons affected bymethylation, especially thosewith higher1124 Cell Reports 10, 1122–1134, February 24, 2015 ª2015 The Authlevels of inclusion in wild-type cells, show a resemblance to
constitutively spliced exons in several attributes. Usually, the
average length of alternatively spliced exons is relatively short
compared to constitutive exons (Gelfman et al., 2012). However,
exons that are included in a methylation-dependent manner
are longer, with an average length comparable to constitutive
exons (Figure 1C). Moreover, similarly to constitutive exons,
methylation-dependent exons have a high G+C content signalors
downstream of the 50 splice site, whereas exons unaffected by
methylation do not (Figure 1D). This downstream G+C signal
was previously shown to have a splicing regulatory role (Amit
et al., 2012). Last, all methylation-affected exons possess stron-
ger 30 splice sites than those unaffected by methylation, again
more in resemblance to constitutive exons (Figure 1E). This dif-
ference in splice site strength was found mainly in 30 splice sites
and was not pronounced for 50 splice sites, suggesting that it is
not a result of G+C structure at the splice site (Figure 1F). This
overall resemblance places exons that are regulated by DNA
methylation on the scale of several factors somewhere in be-
tween unaffected alternative exons and constitutively spliced
exons. Overall, alternative exons whose recognition is sensitive
to DNAmethylation appear to possess particularly strong factors
for recognition yet are not strong enough to overcome the fine-
tuned regulation by methylation (as is the case with constitutive
exons).
We investigated evolutionary conservation of the different
exons that are either regulated or unaffected by DNA methyla-
tion (see Supplemental Experimental Procedures). Interestingly,
we found that methylation-affected exons are significantly more
conserved thanmethylation unaffected exons (Figure 1G; Mann-
Whitney test, p value < 2.2 3 1016 and p value = 2.8 3 1011
for negatively and positively affected exons, respectively). This
finding highlights the biological importance of alternative exons
that are regulated by DNA methylation, as they appear to be
under higher selective pressure compared to other alternative
exons.
We and others previously observed a correlation between
nucleosome occupancy and exon recognition (Schwartz et al.,
2009; Tilgner et al., 2009), and DNA methylation was recently
shown to regulate nucleosome occupancy (Huff and Zilberman,
2014). To examine the possible role of nucleosome occupancy
levels in methylation-dependent exons, we performed MNase-
sequencing experiments to map nucleosome occupancy in the
various exon groups. Alternative exons unaffected by methyl-
ation displayed a weaker nucleosome signal than did constitu-
tive exons, as was previously observed for alternative exons in
general (Schwartz et al., 2009; Tilgner et al., 2009). However,
methylation-dependent alternative exons displayed levels of
nucleosome occupancy similar to those of constitutive exons
in both wild-type and TKO cells (Figures 1H and S1C, respec-
tively). This result supports the previous claim, which places
exons that are regulated by DNA methylation somewhere in
between unaffected skipped exons and the highly recognized
constitutively spliced exons.
Since DNA methylation can modulate RNAPII kinetics (Maun-
akea et al., 2013; Shukla et al., 2011), we asked whether this is
also the case for our methylation-affected exons. We examined
RNAPII occupancy using publicly available chromatin immuno-
precipitation sequencing (ChIP-seq) data from mouse ESCs
(Tiwari et al., 2012). The results exhibit a strong accumulation
of RNAPII immediately upstream of positively affected exons,
while no such accumulation was found on other exons (Fig-
ure S1D). This result suggests that RNAPII pauses near exons
that are positively affected by methylation, pointing to RNAPII
pausing as a possible mechanism for the positive effect of
DNA methylation on splicing, supporting other mechanisms ofCell Raction through the kinetic model such as the case with CTCF
(Shukla et al., 2011) and MeCP2 (Maunakea et al., 2013).
HP1b and DNAMethylation Work in Concert to Regulate
Splicing Decisions
To this point, we have shown that DNA methylation’s effect on
splicing can be bi-directional—it can enhance or suppress inclu-
sion level of alternative exons. Previous studies have uncovered
two mechanisms for methylation-dependent regulation of
splicing (Maunakea et al., 2013; Shukla et al., 2011). However,
these two mechanisms combined can only explain a small frac-
tion of the overall regulatory effect of DNA methylation on
splicing. Our search for other candidates that can directly affect
splicing through DNA methylation has led us to HP1 proteins. As
detailed above, previous evidence links HP1 to splicing regula-
tion in some specific contexts, while other evidence links HP1
to H3K9me3, a heterochromatin-associated histone modifica-
tion that can be co-localized with regions of methylated DNA.
Combining this evidence makes HP1 a promising candidate to
connect DNA methylation and splicing. To extend our observa-
tions on DNA methylation and to test the contribution of HP1
proteins on splicing in a genome-wide manner, we performed
RNA-seq experiments on wild-type mouse ESCs, after knocking
down each and all three HP1 isoforms (Figure 2A). RNA-seq ex-
periments showed that there is a strong overlap among the three
HP1 isoforms in the groups of affected exons, which encom-
passes approximately 70%–80% of the affected exons (Fig-
ure S2). This means that exons that were affected in a specific
manner (positive or negative) by one isoform were usually
affected in the same manner by the other two isoforms. Interest-
ingly, this result suggests that the function of regulating alterna-
tive splicing is not limited to any single HP1 isoform. In fact, all
three HP1 proteins probably share similar modes of action for
alternative splicing regulation. This strong overlap in effects of
all HP1 isoforms enabled us to take HP1b as a sole representa-
tive of this protein family and examine its effects on splicing. Of
2,837 alternative exons that met our strict criteria, 1,266 (44.6%)
exons changed their inclusion levels by more than 10% when
HP1b was knocked down (Figure 2B). Of these, 950 (33.5%)
decreased their inclusion level and thus were positively affected
by HP1b, and 316 (11.1%) increased their inclusion level and
thus were negatively affected by HP1b. These results indicate
that HP1b (as also HP1a and HP1g), akin to DNA methylation it-
self, can influence alternative splicing in both directions, having
both positive (enhancing) and negative (silencing) roles in exon
recognition. We found that exons positively affected by HP1b
are very long, as are exons positively affected by DNA methyl-
ation, while negatively affected exons are short (Figure 2C).
To examine whether splicing regulation by DNA methylation
is related to HP1’s effect, we looked for the exons that are
affected in the same manner (either positively or negatively) by
both DNA methylation and HP1. The results present an overlap
between exons affected similarly by DNA methylation and HP1b
that is highly significant compared to a random distribution (Fig-
ures 2D and 2E; proportions test, p value < 2.2 3 1016; see
Supplemental Experimental Procedures). This points to a strong
correlation between the mechanisms of action involving DNA
methylation and HP1b, as 152 exons, corresponding to 20%eports 10, 1122–1134, February 24, 2015 ª2015 The Authors 1125
Figure 2. Identification and Characterization of HP1b- and DNA Methylation-Dependent Exons
(A) Western blot analysis of protein extracts from R1 wild-type cells treated with indicated siRNAs. HSC-70 was used as loading control.
(B) Distribution of alternative exons based on direction of change in splicing pattern between R1 cells treated with HP1b siRNA and untreated cells.
(C) Average length of upstream introns (left), exons (center), and downstream introns (right) for alternative (three groups) and constitutive exons.
(D) Overlap of exons that were negatively affected by DNA methylation and HP1b.
(E) Overlap of exons that were positively affected by DNA methylation and HP1b.
(F) Normalized HP1b ChIP-seq read signal of negatively (dark green) and positively (purple) affected overlapping exons based on (C) and (D).
(G) Average of methylated CpGs of negatively (dark green) and positively (purple) affected overlapping exons.
*Proportions test, p < 1.3 3 1014; **proportions test, p < 2.2 3 1016. See also Figure S2.(152/752; Figures 2D and 2E) of the methylation-affected exons,
can be explained by HP1 regulation. To study the biological
function of the combined effects of DNA methylation and
HP1, we performed Gene Ontology analysis using the DAVID
tool (Huang da et al., 2009). Exons that are downregulated by
both HP1 and methylation show strong enrichment for genes
that take part in cell differentiation processes (p value =
0.005). This finding is of strong value, since the high methylation
levels found in this group are a strong property of ESCs (Lister
et al., 2009), where regulation of genes involved in differentiation
is of major consequence. Indeed, when we attempt to differen-
tiate the TKO cells by retinoic acid treatment, the cells die after
5 days of treatment, achieving only partial differentiation. This
observation fits well, as misregulation of genes important for
cell differentiation can lead to abnormal differentiation and sub-
sequently to cell death. On the other hand, exons that are upre-
gulated by both factors are enriched in genes that take part in
translation regulation (p value = 0.002) and can play a role in1126 Cell Reports 10, 1122–1134, February 24, 2015 ª2015 The Authregulating gene expression in different tissues and multiple
developmental stages.
To examine HP1b binding profiles in the two exon groups
(exons that are up- or downregulated by both HP1 and DNA
methylation), we analyzed recently published HP1b ChIP-seq
data of wild-type mouse ESCs (Mu¨ller-Ott et al., 2014). Remark-
ably, alternative exons that were negatively regulated by both
methylation and HP1b showed a significant HP1b signal within
the exon itself (t test, p value < 2.2 3 1016), whereas exons
that were positively regulated by both methylation and HP1b
showed HP1b enrichment in the upstream intron (Figure 2F).
We also examined DNA methylation patterns on these exons.
Consistently with the HP1b signal, we found strong methylation
signals at both ends of the negatively affected exons (Figure 2G),
while the positive effect was consistently accompanied by low
methylation levels (see Figure 1B). These results strongly sug-
gest that HP1b, a DNA binding protein, can affect RNA alterna-
tive splicing in a context-dependent manner: it acts as a splicingors
Figure 3. DNA Methylation Directly Affects Alternative Splicing
(A) Diagram illustrating the construction of the methylated and unmethylated EDI minigene experimental system.
(B) Schematic diagram of the EDI minigene. Constitutive and alternative exons are shown in blue and orange, respectively.
(C) Bisulfate sequencing of two representative regions (in red) on genomic DNA from cells containing unmethylated and methylated EDI. Below each plot is the
methylation percentage of each region.
(D) RT-PCR of RNA from cells containing unmethylated and methylated EDI. The upper and lower bands represent inclusion and skipping of alternative exons,
respectively.
(E) qRT-PCR of RNA from cells containing unmethylated and methylated EDI. Exon-exon junction primers for each isoform are represented by red arrows. EDI
inclusion level was calculated by dividing amount of the inclusion isoform by amount of the skipping isoform. Values represent the mean ± SEM (n = 4). Student’s
t test was used to compare the indicated samples. See also Figure S3.silencer when bound to a methylated exon and as a splicing
enhancer when it binds immediately upstream to long exons.
TargetedMethylation of a Single Gene Supports a Direct
Methylation Effect on mRNA Splicing
Thus far, we have shown that DNA methylation can affect
exon splicing bi-directionally. We next aimed to validate our
genome-wide results in an isolated and carefully controlled sys-
tem. To establish a causative connection between the factors at
hand, we constructed an experimental system in which differen-
tial DNA methylation could be limited to a single gene while all
other cellular factors remain identical. For that purpose, we con-
structed a novel biological system that takes advantage of the
fibronectin EDI minigene. This minigene system offers a well-es-
tablished model system that has been used extensively in the
past to study splicing regulatory mechanisms (Iannone and Val-
ca´rcel, 2013). We introduced this minigene, either in vitro CpG
methylated or unmethylated (see Supplemental Experimental
Procedures), into human Flp-In-HEK293 cells using targeted
Flp recombination (Figures 3A and 3B). This system offers threeCell Radvantages. First, the system enabled us to evaluate the effect of
DNA methylation on one gene while the rest of the genome was
unperturbed. Second, the gene was integrated into the genome
and was thus studied in a normal genomic context. Third, meth-
ylated and unmethylated versions were introduced in the same
orientation into the same genomic location, thus eliminating
any confounding positional or other background effects.
Following genomic insertion, we confirmed the methylation state
using bisulfite sequencing for two representative regions and
found that unmethylated EDI remained unmethylated, while
methylated EDI remained mostly methylated after integration
into the cells (Figure 3C). We next examined the splicing pattern
of methylated versus unmethylated EDI exons using RT-PCR
and qRT-PCR. Inclusion levels of the alternatively spliced exons
were significantly higher in cells containing the methylated EDI
gene than in cells containing the unmethylated EDI gene (Figures
3D and 3E). The endogenous EDI exon also displays a similar
pattern, where high levels of DNA methylation coincide with
high exon inclusion (Figure S3). Our genome-wide results indi-
cate that DNA methylation can act as a splicing enhancer oneports 10, 1122–1134, February 24, 2015 ª2015 The Authors 1127
certain exons and as a splicing silencer on another fraction of
exons (Figure 1A). The EDI minigene represents an example for
a splicing enhancing ability. This effect is strongly supported
by the genome-wide analysis (see Figure 1) when considering
the similar structural features of the two EDI alternative exons
and the generally affected exon population; both EDI exons
display a high G+C content signal on the exon sequence and
the sequence downstream of the 50 splice site. Additionally,
the second alternative exon is very long (270 nt), and both exons
have a stronger 30 splice site. Most importantly, this result pro-
vides for the first time a direct and causal link between DNA
methylation and splicing. It indicates that DNA methylation,
specifically on the EDI minigene, is directly involved in splicing
regulation of its alternative exons. This result is accentuated by
the fact that both cell types, harboring either a methylated or
an unmethylated EDI minigene, share identical genomic and
epigenomic backgrounds.
HP1 Mediates DNA Methylation and Splicing
Our genome-wide results indicate that HP1 proteins can regulate
alternative splicing bi-directionally, explaining a substantial
portion of DNA methylation’s global effect on splicing. We next
used our EDI experimental system to validate these genome-
wide results regarding HP1’s part in this mechanism. To test if
HP1 serves as a mediator connecting DNA methylation with
splicing, we first examined the role of HP1 proteins in our system
by overexpressing or knocking down each of the three HP1 iso-
forms (Figure S4A). In the case of an unmethylated EDI, both
overexpression and knockdown of all HP1 isoforms caused a
general slight decrease in EDI inclusion levels (Figures S4B
and S4C). In contrast, when EDI is methylated, HP1manipulation
gave a differential effect: overexpression of HP1 caused a prom-
inent decrease in EDI inclusion (Figure S4B), while knockdown of
HP1 caused an increase in EDI inclusion levels (Figure S4C).
Given that the splicing effect on unmethylated EDI was similar
for both overexpression and knockdown of all HP1 isoforms,
we regard this as a background effect, which is probably indi-
rect. To normalize this background, we divided the effect of
changed HP1 levels on methylated EDI by the respective effect
of changed HP1 levels on unmethylated EDI. Knockdown of
HP1a and HP1b isoforms caused a stronger shift toward higher
inclusion for a methylated EDI minigene, whereas overexpres-
sion of these isoforms produced the opposite effect (Figure 4A).
Notably, changes in levels of HP1g did not significantly affect the
methylation-induced shift in splicing patterns. These results sug-
gest that HP1a and HP1b suppress EDI exon recognition in a
methylation-dependent manner. Our genome-wide results indi-
cate that HP1 can act as a splicing enhancer on a certain group
of exons and as a splicing silencer for a different group of exons
(Figure 2B). In this system, we observe an example for its ability
to interfere with exon recognition when the exon is methylated.
Here, we find that DNA methylation’s ‘‘natural’’ effect is to
enhance exon recognition. However, methylation-dependent
binding of HP1a and HP1b to the minigene disrupts EDI exon
recognition. DNA methylation can regulate splicing through
multiple factors in addition to HP1, both known (Maunakea
et al., 2013; Shukla et al., 2011) and unknown. Here, we observe
a possible competition between factors, meaning that the1128 Cell Reports 10, 1122–1134, February 24, 2015 ª2015 The Authbinding of other methyl binding regulatory proteins might exert
a regulatory effect on EDI alternative splicing that is in competi-
tion with HP1.
To search for the mechanism by which this methylation-
dependent regulation by HP1 occurs, we first investigated how
HP1 proteins bind to the EDI gene using ChIP-qPCR. Impor-
tantly, we found significant enrichment of all three HP1 isoforms
across the methylated, but not the unmethylated, EDI gene, indi-
cating their expected association with methylated DNA. Further-
more, all HP1 proteins show specific binding peaks on the two
methylated alternative exons and in the promoter region (Fig-
ure 4B). This result is fully consistent with our genome-wide ob-
servations, showing that HP1 silenced exon recognition when it
bound to the alternative exon itself (Figure 2F).
It was previously shown that H3K9me3 functions as a
substrate for HP1’s binding to chromatin (Bannister et al.,
2001; Jacobs and Khorasanizadeh, 2002). We therefore used
ChIP-qPCR analysis to examine where along the minigene
H3K9me3 is located. We found enrichment patterns similar to
that of HP1, i.e., a strong enrichment on the methylated, but
not the unmethylated, EDI gene, with specific peaks on the alter-
native exons and the promoter region (Figure 4B). These results
show high correlation between HP1 isoforms and H3K9me3
along the minigene, specifically when alternative exons are
affected. Comparing the signal of H3K9me3 to the nucleosome
occupancy signal on the methylated EDI (Figure S4D; histone
H3) allowed us to safely conclude that H3K9me3 is not a byprod-
uct of increased nucleosome occupancy. Also, other histone
marks such as H3K9me2 and H3K36me3 were largely unaf-
fected by EDI methylation, supporting the expected result that
indeed HP1 isoforms are associated via H3K9me3 (Figure S4D).
HP1 Recruits the Splicing Factor SRSF3
HP1 was previously shown to be associated with splicing fac-
tors SRSF1 in mitotic HeLa cells (Loomis et al., 2009), and
heterogeneous nuclear ribonucleoprotein particles (hnRNPs) in
Drosophila and humans (Ameyar-Zazoua et al., 2012; Piacentini
et al., 2009). To examine whether this interaction occurs in our
system, we performed co-immunoprecipitation assays to probe
for the interaction of HP1 proteins with various splicing factors,
which we suspected could associate with HP1. Of the examined
splicing factors, we found that SF3B1, SRSF1, and SRSF3 bind
to HP1a and HP1b isoforms, but not to HP1g (Figure 4C). This
interaction was not sensitive to RNase treatment (see Experi-
mental Procedures). We did not find HP1 to associate with other
splicing factors such as SRSF6 and hnRNP A2/B1. We also did
not detect any association between HP1 isoforms and RNAPII
(Figure 4C), although this interaction was previously reported in
Drosophila (Piacentini et al., 2009). Our finding that HP1 associ-
ates with SF3B1, a U2 small nuclear ribonucleoprotein particle
(snRNP)-associated protein, led us to examine whether the
whole U2 snRNP associates with HP1. Further co-immunopre-
cipitation experiments showed that all other tested U2 snRNP
components also associated with HP1 (Figure S4E), which sug-
gests that the whole U2 snRNP could be associated with HP1
and that HP1 might help recruit U2 snRNP to H3K9 methylated
histones, similarly to CHD1’s known recruitment of U2 snRNP
to H3K4 methylated histones (Sims et al., 2007). Overall, theors
Figure 4. HP1 Mediates Splicing Changes in a Methylation-Dependent Manner by Recruiting SRSF3
(A) HP1 was overexpressed or knocked down using siRNA in methylated and unmethylated cells, and qRT-PCR analysis using the previously indicated exon-
exon junction primers was used to assess EDI inclusion level of methylated relative to unmethylated cells (n = 3).
(B) ChIP of HP1 isoforms and H3K9me3 in unmethylated and methylated cells and qPCR along the EDI minigene using EIF6 intron 3 for endogenous background
control. Values are ChIP relative to input (n = 3). Dotted and full lines represent the ChIP signal in unmethylated and methylated cells, respectively. Black lines
represent ChIP with rabbit IgG.
(C) Co-immunoprecipitation of HP1 isoforms with various splicing factors and RNA polymerase II (RNAPII) in Flp-In-HEK293 cells.
(D) Indicated splicing factors were overexpressed, and qRT-PCR analysis was used to assess EDI inclusion level of methylated relative to unmethylated cells
(n = 5).
(E) SRSF3 was overexpressed and cells were treated with HP1 siRNA (red) or control siRNA (blue; n = 5). EDI inclusion levels of methylated relative to
unmethylated cells were determined.
(F) HP1a and HP1bwere overexpressed, and cells were treated with SRSF3 siRNA (red) or control siRNA (blue; n = 3). EDI inclusion levels of methylated relative to
unmethylated cells were determined.
All graphs show mean values ± SEM. Student’s t test was used to compare the indicated samples. See also Figures S4 and S5.
Cell Reports 10, 1122–1134, February 24, 2015 ª2015 The Authors 1129
association of HP1 with splicing factors could mean that HP1’s
regulation of alternative splicing involves the recruitment of
splicing factors to methylated DNA.
Thus far, we found that HP1a and HP1b, but not HP1g, regu-
late EDI alternative splicing in a methylation-dependent manner
(Figure 4A) and directly bind to splicing factors (Figure 4C). To
further study the underlying mechanism, we tested whether
HP1 functions as an adaptor protein that recognizes H3K9me3
and recruits splicing factors to the EDI alternative exons. We
overexpressed the HP1-bound splicing factors SF3B1, SRSF1,
and SRSF3 in cells in which EDI was either methylated or unme-
thylated. Overexpression of SRSF1 or SF3B1 did not change the
basic positive shift in EDI inclusion that accompanies methyl-
ation and is observed in the GFP control, whereas overexpres-
sion of SRSF3 reduced the positive splicing shift caused by
DNAmethylation (Figure 4D); this same result was observed pre-
viously when overexpressing HP1a or HP1b (Figure 4A), which
suggests that HP1 might be responsible for recruiting SRSF3
to the methylated EDI gene. SRSF3’s role as a splicing silencer
in the EDI system was previously described (de la Mata and
Kornblihtt, 2006). Therefore, overexpressing SRSF3 is expected
to lower EDI alternative exon inclusion levels regardless of the
methylation state. A deeper examination of the data shows
that this is indeed the case; SRSF3 overexpression decreases
EDI inclusion in both methylated and unmethylated states, but
the magnitude of the effect differs significantly. After overex-
pressing SRSF3, inclusion of the EDI alternative exons shows a
6-fold drop when the gene is methylated but only a 3-fold drop
when the gene is unmethylated (Figure S5A; Student’s t test,
p value = 0.0034). The stronger effect of SRSF3 on a methylated
EDI can be explained by additional recruitment of SRSF3
through HP1 only in a methylated state. To confirm this hypoth-
esis, we overexpressed SRSF3 while simultaneously knocking
down HP1a and HP1b. Indeed, in the absence of HP1a and
HP1b, overexpression of SRSF3 produced a significantly dimin-
ished effect on EDI splicing (Figure 4E). The diminished SRSF3
effect was limited only to the methylated EDI (Figures S5B and
S5C) and was not a result of differences in SRSF3 transfection
levels (Figure S5D). We also performed the reciprocal experi-
ment, where we overexpressed HP1a and HP1b while simulta-
neously knocking down SRSF3. The results further strengthen
this hypothesis, as in the absence of SRSF3, overexpression of
HP1 produced a significantly diminished effect on EDI splicing
(Figure 4F), which suggests that SRSF3 is required for HP1’s
methylation-dependent effect on splicing. Put together, these
findings strongly support a methylation-dependent effect of
SRSF3 on the EDI alternative exons that is mediated by HP1a
and HP1b.
Overall, we present here amechanism that encompasses both
DNA and RNA levels and is controlled epigenetically: methylated
EDI alternative exons are enriched with the H3K9me3 modifica-
tion, which acts as the substrate for HP1 proteins. HP1 proteins
are therefore found particularly on the methylated EDI alternative
exons. The strong association of HP1a and HP1b with SRSF3
enhances SRSF3’s role as a splicing silencer in this system,
lowering the inclusion levels of the EDI alternative exons,
and creates the final link between DNA methylation, HP1, and
splicing regulation.1130 Cell Reports 10, 1122–1134, February 24, 2015 ª2015 The AuthDISCUSSION
The question regarding the impact of DNA methylation on the
splicing process has been raised numerous times in recent years,
yet knowledge about DNA methylation’s regulatory effect re-
mains limited and incomplete. Here, we use a genome-wide
approach to discern DNA methylation’s global ability to regulate
alternative splicing. The various deep-sequencing experiments
that we performed on methylation-deficient cells highlight the
significant global impact that DNAmethylation has on alternative
splicing, both positive and negative. Altered DNA methylation
levels affect the splicing of more than one-fifth of alternative
exons, showing a surprisingly extensive range of influence. In
contrast, DNA methylation did not have a profound effect on
constitutively spliced exons, as almost all constitutive exons in
wild-type cells remain so in TKO cells. We therefore suspect
that DNA methylation is more of a ‘‘fine-tuning’’ mechanism
and is unable to overcome the strong splicing signals inherent
in constitutive exons. Taking into account DNAmethylation’s sig-
nificant influence on splicing of alternative exons, this epigenetic
modificationwill have amajor contribution to current splicingpre-
diction tools suchas the ‘‘splicing code’’ (Barash et al., 2010), and
we strongly support its introduction to these tools.
The finding that constitutive exons exhibit higher methylation
levels than alternative exons implies that DNA methylation pro-
motes exon inclusion. However, we propose that DNA methyla-
tion’s fine-tuned regulation of splicing is only made apparent in
alternative exons whose recognition, unlike constitutive exons,
is not strongly controlled by the basic splicing recognition fac-
tors. When analyzing alternative exons that are affected or unaf-
fected by methylation, we find that the underlying mechanism
is indeed more complex: high methylation levels will repress
recognition of alternative exons, while low methylation levels
will enhance their recognition. We hypothesize that constitutive
exons might have high inclusion in spite of and not because of
high DNA methylation levels, as these exons are controlled by
much stronger intrinsic factors that overshadow DNA methyla-
tion’s weaker effects.
The search for a mediator protein that can affect splicing regu-
lation on the one hand and is selective to DNAmethylation on the
other led us to examine the HP1 protein family. Our global anal-
ysis of the HP1 proteins points to significant similarities between
HP1 and DNA methylation regarding their effect on alternative
splicing. Quite strikingly, our combined genome-wide results
demonstrate that for 152 alternative exons, which represent
20% of the overall effect of DNAmethylation on splicing, splicing
regulation can be explained by an interaction with HP1. This cor-
relation is highly significant compared to random chance. The
number of exons that are affected here is not large, but it reflects
other mechanisms of refined splicing regulation by DNA binding
proteins such as those published by a landmark study done by
Luco et al. showing that 65 exons, which correspond to 14%
of PTB-regulated exons, could be explained by regulation
through MRG15 (Luco et al., 2010). In addition to DNA methyl-
ation, there might be other potential mechanisms for HP1-medi-
ated alternative splicing, as HP1was previously shown to bind to
RNA (Muchardt et al., 2002). The existence of other, methylation-
independent mechanisms could explain the non-overlappingors
Figure 5. A Model for How HP1 Links DNA Methylation to Alternative Splicing in the EDI System
(A) When DNA is unmethylated, RNAPII (blue) transcribes the pre-mRNA molecule and the EDI alternative exon (dark brown) is included in the mature transcript.
(B)When DNA ismethylated (dark red circle), the histonemodification H3K9me3 (three red circles) is present andHP1 (purple) binds to the chromatin. The splicing
factor SRSF3 (pink) binds to HP1 and is transferred to the pre-mRNA, resulting in skipping of the EDI alternative exon in the mature transcript.alternative splicing events. Overall, our results suggest that
HP1 serves an important function as a mediator between DNA
methylation and splicing, thus adding another layer of regulation
to other known mechanisms of splicing regulation through DNA
methylation such as CTCF (Shukla et al., 2011) and MeCP2
(Maunakea et al., 2013). Remarkably, our ChIP-seq results
demonstrate a localization specific effect for HP1 on RNA
splicing (Figure 2F): HP1 enhances the inclusion of exons when
bound immediately upstream to the exon and silences exon
recognition when bound to the exon itself. This position-specific
effect has been observed before for multiple RNA binding pro-
teins such as PTB (Llorian et al., 2010) and hnRNP proteins
(Huelga et al., 2012) and is shown here for the first time for a
DNA binding protein.
A strong backup to our genome-wide analysis was performed
using a newly introduced system that uses site-specific targeting
of a methylated gene versus an unmethylated gene. This system
produced two major discoveries.
First, the overwhelmingmajority of papers dealing with regula-
tion of alternative splicing by DNA methylation make use of
correlational observations. Consequently, the major question in
the field—whether there is a direct link between methylation
and splicing—remained unanswered. Here, using our EDI exper-
imental system, we were able to switch on or switch off DNA
methylation in a single gene while keeping the endogenous
background unchanged. This enormous advantage allowed us
to overcome that common limitation and demonstrate for the
first time a causal relationship between DNA methylation and
alternative splicing.
Second, using our EDI experimental system, we show that
HP1 is an adaptor protein that connects DNA methylation toCell Rsplicing by recruiting splicing factors. We found that HP1a and
HP1b bind to methylated EDI alternative exons and recruit the
splicing factor SRSF3, thus enhancing SRSF3’s role as a splicing
silencer in this system and lowering the inclusion levels of the EDI
alternative exons in their methylated state. DNA methylation has
been shown previously to regulate splicing through an impact
on the kinetics of RNAPII elongation (Maunakea et al., 2013).
However, the mechanism presented here represents the first
reported example of DNA methylation’s ability to regulate alter-
native splicing through the recruitment model. We therefore
propose a model by which HP1 binds to the DNA methylation-
associated histone modification H3K9me3 and recruits splicing
factors specifically to methylated alternative exons (Figure 5).
This recruitment reduces exon recognition in the EDI system,
where HP1 binds to the EDI alternative exons. HP1 can also
enhance exon recognition in other cases, where it binds up-
stream to the alternative exons, as our results show a localiza-
tion-specific effect for HP1 on splicing (Figure 2F).
Our RNA-seq experiments show that all three HP1 isoforms
can regulate alternative splicing. Moreover, our results display
a high level of overlap (70%–80%) between the exon populations
that were affected by the different HP1 proteins (Figure S2), sug-
gesting that the HP1 isoforms probably share similar modes of
action. However, while this overlap is high, it is not complete,
leaving the possibility for specific cases where HP1 proteins
only partially overlap. The EDI system represents such a case,
as both HP1a and HP1b affect alternative splicing similarly,
whereas HP1g does not strongly affect alternative splicing in
this system.
The involvement of HP1 in the regulation of splicing by
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conditions, such as cancer, where widespread changes in levels
of DNA methylation and aberrant alternative splicing patterns
have been reported (David and Manley, 2010; Hodges et al.,
2009), while overexpression of HP1 has also been detected in
multiple cancer cell lines and is thought to play a role in tumori-
genesis (Takanashi et al., 2009). Indeed, we found several known
cases where alternative exons similarly regulated by both DNA
methylation andHP1 are involved in cancer: theMnk splicing iso-
form that includes exon 13 was found to be tumor suppressive
and is downregulated in breast, lung, and colon tumors (Maimon
et al., 2014); exon 12 of the Irak1 gene affects its ability to phos-
phorylate and activate the NF-kB pathway (Carpenter et al.,
2014) and is an oncotarget in both myelodysplastic syndromes
and acute myeloid leukemia cancers (Beverly and Starczynow-
ski, 2014; Rhyasen et al., 2013); and exon 6 of the Myl6 gene
and exon 8 of the App gene were found to have differential
splicing patterns in breast cancer and lung cancer, respectively
(Li et al., 2006; Misquitta-Ali et al., 2011). These examples high-
light the importance of HP1-mediated regulation of splicing by
DNA methylation on cancer progression.
Finally, it is likely that additional methylation-dependent
splicing regulatory proteins exist, and the novel model system
that we present here offers the scientific community a unique
opportunity to probe and discover such proteins in the future.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures can be found in Supplemental Experimental
Procedures.
Cells and Plasmids
Flp-In-HEK293 cells were from Invitrogen. Mouse R1 ESCs were from ATCC.
Dnmt TKO ESCs were a kind gift from Prof. Masaki Okano (RIKEN) and have
been previously described previously (Tsumura et al., 2006). The expres-
sion plasmids encoding HP1a-GFP, HP1b-GFP, HP1g-GFP, SRSF1-T7, and
SRSF3-T7 were previously described (Ca´ceres et al., 1997; Cheutin et al.,
2003). The expression plasmid encoding the SF3B1-GFP fusion protein was
a kind gift from Prof. Juan Valcarcel (Centre de Regulacio´ Geno`mica).
pSVEDA/FN containing the EDI minigene was a kind gift from Prof. Alberto
Kornblihtt (Universidad de Buenos Aires) and has been previously described
(Cramer et al., 1999). The EDI minigene was introduced into pcDNA5/FRT/
TO (Invitrogen) for stable integration into the cells.
EDI Bisulfite Sequencing
DNA was extracted from cells, bisulfite converted, and PCR amplified. The
PCR product was cloned into a plasmid and transformed into bacteria. DNA
from several colonies was extracted and sequenced using the forward primer
from the PCR reaction.
Analysis of Splicing Patterns by RT-PCR and qRT-PCR
Total RNA was reverse transcribed using SuperScript III (Invitrogen). For
RT-PCR analysis, PCR was performed using Biotools DNA Polymerase, and
resulting products were visualized on agarose gels. For qRT-PCR, qPCR
was performed using KAPA SYBR FAST on a Stratagene Mx3005P thermo-
cycler using exon-exon junction primer pairs designed to detect the inclusion
or skipping isoforms.
Overexpression and siRNA Knockdown
Expression plasmids were transfected using TransIT-LT1 (Mirus), and cells
were incubated for 48 hr before RNA and proteins were extracted. In all exper-
iments, an empty pEGFP-C3 plasmid was used for control. Knockdowns were
performed using siGENOME small interfering RNAs (siRNAs) (Dharmacon).
Stable cells were transfected using Lipofectamine RNAiMAX (Invitrogen) and1132 Cell Reports 10, 1122–1134, February 24, 2015 ª2015 The Authincubated for 96 hr before RNA and proteins were extracted. R1 and TKO cells
were transfected using Lipofectamine 2000 (Invitrogen) and incubated for
48 hr before RNA and proteins were extracted.
Co-immunoprecipitation
Cells were washed with PBS, and nuclei were purified and treated with MNase
to release chromatin-bound proteins, then re-suspended in immunoprecipita-
tion (IP) buffer and incubated with antibody conjugated to protein A Dyna-
beads (Invitrogen). Samples were incubated with RNase A and washed with
IP buffer. Proteins were eluted and subjected to western blot analysis.
ChIP
Cells were cross-linked using formaldehyde, lysed, and sonicated to obtain an
average DNA size of 150–350 bp. Chromatin was incubated with antibody con-
jugated to protein A Dynabeads (Invitrogen). Samples were stringently washed
using several buffers. DNAwas eluted, treated with RNase A and Proteinase K,
and incubated at 65C to reverse the cross-links. DNA was purified using
MinElute PCR purification kit (QIAGEN) followed by qPCR analysis.
Library Preparation and Deep Sequencing
RNA-seq library preparation was performed using commercially available kits
from Illumina. Deep sequencing was carried out on an Illumina Genome
Analyzer II or Illumina HiSeq 2000.
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